GlaxoSmithkline Consumer Healthcare (Delisted) share news and announcements
BSE: 500676
Formerly Smithkline Beecham Consumer Healthcare
Last traded ₹10,732.60 on 15 Apr 2020
Delisted on 24 Jun 2021.
GlaxoSmithkline Consumer Healthcare share news and announcements
668 announcements, routine notices left out, newest first. Page 10 of 14.
Aug 2013
1 Aug · Management
Ms. Sonali Khanna has been appointed as the Company Secretary w.e.f. August 01, 2013 in place of Mr. Surinder Kumar, who had decided to step down as the Company Secretary of the Company.Further, Ms. Sonali Khanna shall also act as the Compliance Officer with effect from August 01, 20131 Aug · Change of Company Secretary
Ms. Sonali Khanna has been appointed as the Company Secretary w.e.f. August 01, 2013 in place of Mr. Surinder Kumar, who had ....1 Aug · Results
Standalone Results for the quarter ended on 30-JUN-2013 as follows: Net Sales of Rs. 85292 lacs for the quarter ending on 30-JUN-2013 against Rs. 93986 lacs and Rs. 72973 lacs for the quarters ending on 31-MAR-2013 and 30-JUN-2012 respectively. Net Profit / (Loss) of Rs. 11996 lacs for the quarter ending on 30-JUN-2013 against Rs. 15641 lacs and Rs. 10660 lacs for the quarters ending on 31-MAR-2013 and 30-JUN-2012 respectively.
Jul 2013
16 Jul · Board meeting
To, inter alia, consider and take on record the Unaudited Financial Results for the quarter ended on June 30, 2013 with Limited Review done by the Statutory Auditors.15 Jul · Board meeting
Meeting of the Board of Directors of the Company will be held on August 01, 2013, inter alia, to consider and take on record ....
Jun 2013
May 2013
2 May · Board meeting
Board of Directors of the Company at its meeting held on May 01, 2013, has noted the withdrawal of nomination by Horlicks Limited of Mr.Simon Scarff as the Director of the Company and as the Chairman of the Board w.e.f. close of business hours as on April 30, 2013 & accepted the resignation of Mr.Subodh Bhargava as an elected Director. The Board appointed Ms.Ireena Vittal as a Director of the Company, in the casual vacancy caused by the resignation of Mr.Subodh Bhargava. Pursuant to Article 97A of the Articles of Association, Horlicks Limited has appointed Mr.Subodh Bhargava as a Director on the Board. Further, the Board has appointed Mr.Subodh Bhargava as the Chairman of the Board w.e.f. May 01, 2013.2 May · Board meeting
Board of Directors of the Company at its meeting held on May 01, 2013, inter alia, has noted the withdrawal of nomination ....
Apr 2013
16 Apr · Board meeting
To, inter alia, consider and take on record the Unaudited Financial Results for the quarter ended on March 31, 2013 with Limited Review done by the Statutory Auditors.16 Apr · Results
Meeting of the Board of Directors of the Company will be held on May 01, 2013, inter alia, to consider and take on record ....9 Apr · Board meeting
At the Board Meeting held on Tuesday, April 9, 2013 Mr. Simon Scarff, Chairman of the Board of Directors, has expressed his desire to step down as the Chairman of the Company w.e.f. close of business hours on April 30, 2013.9 Apr · Board meeting
Board of Directors of the Company at its meeting held on April 09, 2013, Mr. Simon Scarff, Chairman of the Board of Directors, ....2 Apr · Board Meeting on April 09, 2013
Meeting of the Board of Directors of the Company will be held on April 09, 2013, to consider and approve re-constitution ....
Mar 2013
Feb 2013
25 Feb · Updates
Vide letter dated February 18, 2013 that "As per the guideline on Institutional Transactions in shares issued by Govt. of India on February 20, 1990, we hereby inform that Life Insurance Corporation of India has sold 16,71,579 equity shares (of face value of Rs.10/- each) of GlaxoSmithkline Consumer Healthcare Ltd. @ Rs.3900/- per share".18 Feb · Corporate action
Company has fixed Book Closure from March 21, 2013 to April 9, 2013 both days inclusive for the purpose of Dividend and the Annual General Meeting18 Feb · Dividend
Board of Directors of the Company at its meeting held on February 15, 2013, inter alia, has recommended a Dividend at the rate of Rs. 45 per equity share of Rs. 10 each.18 Feb · Dividend
Dividend shall be paid to the entitled Members on or before May 08, 2013.18 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 15, 2013 has transacted the following:(1) Re-appointed Mr. Zubair Ahmed as Managing Director of the Company for the period from June 01, 2013 to May 31, 2017. Mr. Zubair Ahmed's terms of appointment and remuneration are subject to the approval of the shareholders.(2). The Board also approved the change in Financial Year of the Company from Calendar Year to Financial Year w.e.f. January 01, 2013 to March 31, 2014 and thereafter the Financial Year will be from April 01 to March 31.15 Feb · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from March 21, 2013 to April 09, 2013 (both ....15 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 15, 2013, inter alia, has transacted the following: ....15 Feb · Dividend
Board of Directors of the Company at its meeting held on February 15, 2013, inter alia, has recommended a Dividend at the ....6 Feb · Board meeting
To, inter alia, consider and take on record the Audited Financial Results for the year ended December 31, 2012 and to consider Dividend for the year ended December 31, 2012.5 Feb · Results
Meeting of the Board of Directors of the Company will be held on February 15, 2013, inter alia, to consider and take on record ....
Jan 2013
Dec 2012
4 Dec · Board meeting
Inter alia, to take note of the 'Voluntary open offer' dated November 26, 2012 by GlaxoSmithKline Pte Limited ('Acquirer') along with Horlicks Limited, and GlaxoSmithKline plc, in their capacity as persons acting in concert (PAC's) with the Acquirer, made to the equity shareholders of GlaxoSmithKline Consumer Healthcare Limited to acquire equity shares pursuant to SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and to consider other incidental matters related thereto.4 Dec · Board Meeting on Dec 10, 2012
Meeting of the Board of Directors of the Company will be held on December 10, 2012, inter alia, to take note of the ‘Voluntary ....